FDA Inspection 1055858 — NEURAXIS, INC
The FDA completed an inspection of NEURAXIS, INC on Jun 6, 2018 in Carmel, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 6, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Carmel, IN (United States)
Additional Details
Sponsor, Contract Research Organization